Clinical Trials Directory

Trials / Completed

CompletedNCT03300726

Synaptic Injury and Functional Connectivity in Alzheimer's Disease

Cerebrospinal Fluid Markers of Synaptic Injury and Functional Connectivity in Alzheimer's Disease

Status
Completed
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
Ohio State University · Academic / Other
Sex
All
Age
60 Years – 95 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine cross-sectional associations between CSF markers of synaptic injury (Ng and SNAP-25) and functional connectivity in default and semantic memory networks using 3T- fMRI in individuals with MCI (i.e. the earliest clinically detectable stage of cognitive impairment) due to AD or mild AD dementia (CDR 0.5-1; n=20) and cognitively normal controls (CDR 0; n=20).

Detailed description

SPECIFIC AIMS: Aim 1: Investigate correlations between CSF biomarkers of synaptic injury (Ng and SNAP-25) and functional connectivity (FC) within the default mode network (DMN) using resting-state fMRI (adjusting for age, gender, apolipoprotein-E4 \[APOE4\] genotype, task performance, and regional brain atrophy) in MCI/AD and controls. Aim 2: Examine correlations between CSF biomarkers of synaptic injury and functional connectivity (FC) within the semantic memory network on task-activated fMRI using the Famous Name Discrimination Task (FNDT) (adjusting for age, gender, APOE4 genotype, task performance, and regional brain atrophy) in MCI/AD and controls.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCSF analysisCSF analysis for tau, p-tau181, Abeta42, and CSF levels of markers of synaptic injury
RADIATIONFunctional MRIFunctional MRI during resting state and semantic memory task activation

Timeline

Start date
2018-02-12
Primary completion
2021-09-22
Completion
2021-09-22
First posted
2017-10-03
Last updated
2021-09-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03300726. Inclusion in this directory is not an endorsement.